Alma Ata 40

Equity & Health‏ @equitylist

Alma-Ata at 40 years: reflections from the Lancet Commission on Investing in Health

• Download PDF [1 MB]
• Figures
• Save
• Share
• • Reprints
  • Request
• Top

Alma-Ata at 40 years: reflections from the LancetCommission on Investing in Health

• David A Watkins, MD  *
• Prof Gavin Yamey, MD *
• Marco Schäferhoff, PhD
• Olusoji Adeyi, DrPH
• Prof George Alleyne, MD
• Prof Ala Alwan, MD
• et al.
• Show all authors
• Show footnotes

Published:October 20, 2018DOI:https://doi.org/10.1016/S0140-6736(18)32389-4

PlumX Metrics

• Executive summary
• Introduction
• Is grand convergence by 2035 still feasible?
• The future of domestic health policy, universal health coverage, and primary health care
• The future of health ODA and international collective action for health
• Conclusions
• Supplementary Material
• References
• Article Info
• Figures
• Tables

Sign up to receive Update 

alerts in your specialty

Executive summary

In 2013, the Lancet Commission on Investing in Health published its report, “Global health 2035: a world converging within a generation” (GH2035). The report concluded that a grand convergence in health—a reduction in infectious, child, and maternal mortality to rates seen in the best-performing middle-income countries—is technically and financially feasible for all but the poorest countries by 2035. Mortality from non-communicable diseases could be reduced through inexpensive population-based and clinical interventions, especially fiscal policies such as heavy tobacco taxation. Pro-poor pathways to universal health coverage, such as publicly financed insurance, would provide financial protection and essential health-care interventions to everyone—ensuring high-quality, low-cost services at the point of care. And the returns on investing in health, based on methods that include both the benefits of improved economic productivity and the intrinsic value of health, would far exceed the costs.

8:58 AM - 19 Oct 2018